Efficacy of Gemfibrozil as an Adjunct to Sertraline in Major Depressive Disorder, A Double-Blind, Randomized, and Placebo-Controlled Clinical Trial

Objective: Major depressive disorder (MDD) is predicted to be one of the biggest disease burden in the future. The antidepressant activity of gemfibrozil has been recently considered. In this study, we assessed the effectiveness of gemfibrozil as a sertraline adjunct in treating patients with MDD. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Zandifar, Atefeh, Badrfam, Rahim, Shamabadi, Ahmad, Jalilevand, Shakiba, Pourmirbabaei, Shayan, Torkamand, Farbod, Sahebolzamani, Erfan, Akhondzadeh, Shahin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Psychiatry & Psychology Research Center, Tehran University of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140300/
https://www.ncbi.nlm.nih.gov/pubmed/34054983
http://dx.doi.org/10.18502/ijps.v16i1.5379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140300/
https://www.ncbi.nlm.nih.gov/pubmed/34054983
http://dx.doi.org/10.18502/ijps.v16i1.5379

Ejemplares similares